Search

everythinglearnresearchcommunity

for

Search:↓

The protein CTCF is essential for skin development, maintaining hair follicles, and preventing inflammation.

Cells from concentrated growth factor can become different cell types.

Gilles de la Tourette syndrome is treatable, with behavioral therapy as a recommended first option and other treatments available for more severe cases.

The system allows precise control of gene expression in mouse skin, useful for studying skin biology.

TQC shows promise for better hair regrowth in treating hair loss.

Disrupting the Tsc2 gene in certain cells leads to thicker skin, larger hair, and changes in hair growth signaling, which can be partly reversed with specific treatment.

Transit-amplifying cells are crucial for tissue repair and can contribute to cancer when they malfunction.

Tgm2 helps stabilize dying cells and aids fibroblast attachment to the extracellular matrix.

Researchers found a specific T cell receptor linked to severe drug reactions like Stevens-Johnson syndrome when patients take carbamazepine.

Tiger tail banding and hair abnormalities are reliable indicators for diagnosing trichothiodystrophy.

Cannabinoid and steroid-based drugs could be new treatments for Tourette syndrome, but more research is needed to confirm their effectiveness and safety.

TS-13 speeds up hair regrowth after chemotherapy.

3,4,5-tri-O-caffeoylquinic acid promotes hair growth by activating the β-catenin pathway.

The research found a way to develop hair growth materials by targeting a specific signaling pathway.

Finasteride significantly reduced tics and obsessive-compulsive symptoms in patients with Tourette syndrome.

CCC1 is essential for ion balance and proper plant cell function.

TCDD reduces EGF receptors in the liver, affecting growth and development.

CTE can distort results in hair growth trials, so exclude it carefully.

Personalized sonidegib dosing can effectively treat Gorlin-Goltz syndrome with fewer side effects.

Eating phenylthiocarbamide made all the rats' hair go gray, but some returned to their original color after stopping.

NBCCS and BFHS might be the same syndrome, helping better identify and manage cases.

TTD patients don't have a higher skin cancer risk because their main issue is with transcription, not DNA repair.

Thioglycolic acid and L-cysteine change hair structure differently during perms, affecting hair strength and curling efficiency.

The report expanded knowledge of MBTPS1-related disorders by identifying new symptoms.

Cyclosporin A, a drug, reduces TGF-β2 expression in skin cells, potentially causing excessive hair growth through a process involving the calcineurin/NFAT pathway.

A new classification for trichothiodystrophy helps identify genetic causes and potential treatments.

GTL1 is needed to control root hair growth and prevent problems when there are too many nutrients.

Lack of TG2 increases fat storage and lowers cell cleanup in skin oil cells.

Topical GT20029 effectively promotes hair regrowth and is well-tolerated for treating androgenetic alopecia.

Sacituzumab govitecan improves quality of life and extends life for breast cancer patients compared to standard chemotherapy.